Methylation status and protein expression of RASSF1A in breast cancer patients

Molecular Biology Reports

Volumn 41, Issue 1, 2014, Pages 57-65

  Hagrass, Hoda A ^a   Pasha, Heba F ^b   Shaheen, Mohamed A ^b   Abdel Bary, Eman H ^b   Kassem, Rasha ^b  

^a Zagazig University   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Breast cancer; Egypt; Methylated polymerase chain reaction; RAS association domain family protein 1A

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADULT; ARTICLE; BREAST CANCER; BREAST LESION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EGYPTIAN; ETHNIC GROUP; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN METHYLATION; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A GENE; RELIABILITY; SENSITIVITY AND SPECIFICITY; TUMOR INVASION;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; TUMOR SUPPRESSOR PROTEINS;

EID: 84891929920     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2837-3     Document Type: Article

References (43)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics. CA Cancer J Clin 55:74-108
2. Allam MF, Abd Elaziz KM (2012) Evaluation of the level of knowledge of Egyptian women of breast cancer and its risk factors. A cross sectional study. J Prev Med Hyg 53(4):195-198
3. Gobel G, Auer D, Gaugg I, Schneitter A, Lesche R, Muller-Holzner E, Marth C, Daxenbichler G (2011) Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patient. Breast Cancer Res Treat 130:109-117
4. Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P (2004) Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 10:6189-6193
5. Sidransky D (2002) Emerging molecular markers of cancer. Nat Rev Cancer 2:210-219
6. Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3:253-266
7. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa J-PJ (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141-196
8. Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21:163-167
9. Belinsky SA, Nikula KJ, Palmisano WA et al (1998) Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95:11891-11896
10. Esteller M, Sparks A, Toyota M et al (2000) Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60:4366-4371
11. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229
12. Lehmann U, Langer F, Feist H, Glockner S, Hasemeier B, Kreipe H (2002) Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol 160:605-612
13. Holst CR, Nuovo GJ, Esteller M, Chew K, Baylin SB, Herman JG, Tlsty TD (2003) Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 63:1596-1601
14. Yamamoto N, Nakayama T, Kajita M, Miyake T, Iwamoto T, Kim SJ, Sakai A, Ishihara H, Tamaki Y, Noguchi S (2012) Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARb2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay. Breast Cancer Res Treat 132:165-173
15. Kloten V, Becker B, Winner K, Schrauder GM, Fasching AP, Anzeneder T, Veeck J, Hartmann A, Knüchel R, Dahl E (2013) Promoter hypermethylation of the tumorsuppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening. Breast Cancer Res 15:R4
16. Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG, Chi SG (2001) Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res 61:6688-6692
17. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallo A, Rader J, Fullwood P, Chauhan A et al (2001) Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 20:1509-1518
18. Alvarez C, Tapia T, Cornejo V, Fernandez W, Alex M, Camus M, Alvarez M, Devoto L, Carvallo P (2012) Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer. Mol Carcinog 52:475-487. doi: 10.1002/mc.21881
19. Dammann R, Yang G, Pfeifer GP (2001) Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 61:3105-3109
20. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Virmani A, Bader Y, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gadzar AF, Lerman MI, Zabarovsky E, White M, Minna JD (2001) The RASSF1A locus in the 3p21.3 homozygous deletion region: epigenetic inactivation in lung and breast cancer and suppression of the malignant phenotype. J Natl Cancer Inst (Bethesda) 93:691-699
21. Lo KW, Kwong J, Hui ABY, Chan SYY, To KF, Chan ASC, Chow LSN, Teo PML, Johnson PJ, Huang DP (2001) High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61:3877-3881
22. Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ (2000) Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 275:35669-35672
23. Tavassoéli FA, Devilee P (2003) Pathology and genetics tumours of the breast and female genital organs [M]. IARC Press, Lyon, p 10
24. Herman J, Graff J, Myhanen S, Nelkin B, Baylin S (1996) Methylation specific PCR: a noval PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826
25. Rountree MR, Bachman KE, Herman JG et al (2001) DNA methylation, chromatin inheritance, and cancer. Oncogene 20:3156-3165
26. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428
27. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427-5440. doi: 10.1038/sj.onc.1205600
28. Jeronimo C, Monteiro P, Henrique R, Costa I, Costa VL, Filipe L, Hoque MO, Pais I, Leal C, Teixeira MR, Sidransky D (2008) Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions. Breast Cancer Res Treat 109:27-34
29. Park SY, Kwon HJ, Lee HE, Ryu HS, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH (2011) Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch 458:73-84
30. Cho YH, Shen J, Gammon MD, Zhang YJ, Wang Q, Gonzalez K, Xu X, Bradshaw PT, Teitelbaum SL, Garbowski G, Hibshoosh H, Neugut AI, Chen J, Santella RM (2012) Prognostic significanceof gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat 131:197-205
31. Li Y, Wei Q, Cao F, Cao X (2008) Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women. Oncol Rep 19:1149-1153
32. Karray-Chouayekh S, Trifa F, Khabir A, Boujelbane N, Sellami-Boudawara T, Daoud J, Frikha M, Jlidi R, Gargouri A, Mokdad-Gargouri R (2010) Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients. J Cancer Res Clin Oncol 136:203-210
33. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7:536-540
34. Waki T, Tamura G, Sato M, Motoyama T (2003) Age-related methylation of tumor suppressor and tumour-related genes: an analysis of autopsy samples. Oncogene 22:4128-4133
35. Bae YK, Brown A, Garrett E, Bornman D, Fackler MJ, Sukumar S et al (2004) Hypermethylation in histologically distinct classes of breast cancer. Clin Cancer Res 10:5998-6005. doi: 10.1158/1078-0432.CCR-04-0667
36. Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti-Domenici J, Polyak K, Argani P, Naab T, Garrett E, Parmigiani G, Broome C, Sukumar S (2004) Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res 10:2052-2057
37. Muller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, Perkmann E, Marth C, Widschwendter M (2003) DNA methylation in serum of breast cancer patients: an independent prog- nostic marker. Cancer Res 63:7641-7645
38. Sunami E, Shinozaki M, Sim M, Nguyen SL, Vu A, Giuliano AE, Hoon DSB (2008) Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. Breast Cancer Res 10:R46
39. Feng W, Orlandi R, Zhao N, Carcangiu ML, Tagliabue E, Xu J, Bast RC Jr, Yu Y (2010) Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers. BMC Cancer 10:378
40. Van der Auwera I, Bovie C, Svensson C, Trinh XB, Limame R, van Dam P, van Laere SJ, van Marck EA, Dirix LY, Vermeulen PB (2010) Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. BMC Cancer 10:97
41. Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE, Sukumar S (2001) Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 357:1335-1336
42. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, Garrett E, Argani P, Sukumar S (2004) Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64(13):4442-4452
43. Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, Wood T, Jeronimo C, Rosenbaum E, Stern J, Yu M, Trink B, Kiviat NB, Sidransky D (2006) Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 24:4262-4269